The 341 MDS patients were subsequently divided into the higher‐ and lower‐ RUNX1 expression (higher‐ and lower‐ RUNX1) groups with the median value (62.49 TPM) of the RUNX1 expression as the cut‐off level. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.